Please login to the form below

Not currently logged in
Email:
Password:

Quintiles, HKPI and Ramco form Egyptian JV

New company, HKPI-JV, will provide specialised contract sales force and sales promotion outsourcing services to Egyptian biopharma companies

Quintiles has formed a joint venture with Health Kare Pharma International (HKPI) and Ramco Import and Export to provide specialised pharmaceutical contract sales force and sales promotion outsourcing services in Egypt.

HKPI is an Egyptian firm offering sales and marketing support for major local manufacturers, and Ramco is the agent/importer in Egypt for several multinational pharmaceutical companies and an affiliate company of Global Napi Pharmaceuticals.

Known as HKPI-JV, with principal offices in Cairo, the new company will assist bio-pharmaceutical companies commercialise therapies in Egypt by recruiting, training and placing pharmaceutical sales representatives; forming and managing outsourced sales and medical marketing teams; product marketing; and sales forecasting.

HKPI-JV will begin operations during the fourth quarter of 2010.

Commenting on the joint venture, Rich Pilnik, executive vice president of Quintiles and president of global commercial solutions stated: "We have allied with these biopharma companies to expand our commercial service offerings into a new market that is an attractive point of entry into the region."

"The biopharma market in Egypt has tremendous growth potential and biopharma customers in the region now have a resource that brings the best of both local and global expertise to the table," Pilnik said.

30th September 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics